Selected article for: "cell cytotoxicity and NK cell"

Author: Kaur, Kawaljit; Ko, Meng-Wei; Ohanian, Nick; Cook, Jessica; Jewett, Anahid
Title: Osteoclast-expanded super-charged NK-cells preferentially select and expand CD8+ T cells
  • Cord-id: bf8s82u0
  • Document date: 2020_11_23
  • ID: bf8s82u0
    Snippet: Osteoclasts (OCs) and much less dendritic cells (DCs) induce significant expansion and functional activation of NK cells, and furthermore, the OC-expanded NK cells preferentially increase the expansion and activation of CD8+ T cells by targeting CD4+ T cells. When autologous OCs were used to expand patient NK cells much lower percentages of expanded CD8+ T cells, decreased numbers of expanded NK cells and decreased functions of NK cells could be observed, and the addition of allogeneic healthy O
    Document: Osteoclasts (OCs) and much less dendritic cells (DCs) induce significant expansion and functional activation of NK cells, and furthermore, the OC-expanded NK cells preferentially increase the expansion and activation of CD8+ T cells by targeting CD4+ T cells. When autologous OCs were used to expand patient NK cells much lower percentages of expanded CD8+ T cells, decreased numbers of expanded NK cells and decreased functions of NK cells could be observed, and the addition of allogeneic healthy OCs increased the patients’ NK function. Mechanistically, OC-expanded NK cells were found to lyse CD4+ T cells but not CD8+ T cells suggesting potential selection of CD8+ T cells before their expansion by OC activated NK cells. In agreement, Increased IFN-γ secretion, and NK cell-mediated cytotoxicity and higher percentages of CD8+ T cells, in various tissue compartments of oral tumor-bearing hu-BLT mice in response to immunotherapy by OC-expanded NK cells were observed. Thus, our results indicate an important relationship between NK and CD8+ T cells.

    Search related documents:
    Co phrase search for related documents
    • absence presence and activating signal: 1
    • absence presence and adaptive cellular immunity: 1
    • absence presence and long term disease control: 1
    • absence presence and low ability: 1
    • absence presence and low capacity: 1, 2
    • absence presence and low number: 1, 2, 3
    • absence presence and low recovery: 1
    • absence presence and lung cancer: 1, 2, 3, 4
    • absence presence and lymphocyte number: 1
    • absence presence and lymphocyte number count: 1
    • action mechanism and long term disease control: 1
    • action mechanism and low capacity: 1
    • action mechanism and low cytotoxicity: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
    • action mechanism and low percentage: 1
    • action mechanism and lung cancer: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
    • action mechanism and lung cancer breast: 1, 2
    • action mechanism and lung cancer breast prostate: 1